Pesticide Experimental Use Permit; Receipt of Application; Comment Request, 48691-48692 [2021-18776]

Download as PDF Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices Until such time as meter configuration is accomplished, the entity will be responsible for charges assessed under the formula rate in effect. Rate Schedule L–AS5 (Supersedes Rate Schedule L–AS5 dated October 1, 2011, through September 30, 2016) Rocky Mountain Region Loveland Area Projects and Western Area Colorado Missouri Balancing Authority Operating Reserve—Spinning Reserve Service (Approved Under Rate Order No. WAPA–174) Effective The first day of the first full billing period beginning on or after October 1, 2016, and extending through September 30, 2021, or until superseded by another rate schedule, whichever occurs earlier. [Note: This rate schedule was extended by Rate Order No. WAPA–196 through September 30, 2024.] khammond on DSKJM1Z7X2PROD with NOTICES Applicable This rate schedule applies to Loveland Area Projects (LAPT) as the Transmission Service Provider (TSP) and to Western Area Colorado Missouri Balancing Authority (WACM) as the Control Area operator. Spinning Reserve Service is needed to serve load immediately in the event of a system contingency. Spinning Reserve Service may be provided by generating units that are on-line and loaded at less than maximum output. The LAPT TSP must offer this service when transmission service is used to serve load within WACM and the Federal Transmission Customers must purchase this service from the LAPT TSP or make alternative comparable arrangements with WACM to satisfy their Spinning Reserve obligations. WACM may be willing to provide Spinning Reserves to other entities, providing the entities enter into separate agreements with WACM which will specify the terms of the Spinning Reserve Service. Formula Rate The LAPT TSP and WACM have no Spinning Reserves available for sale. At a customer’s request, the Rocky Mountain Region will purchase Spinning Reserves and pass through the cost and any activation energy, plus a fee for administration. The customer will be responsible for providing the Jkt 253001 BILLING CODE 6450–01–P Rocky Mountain Region Loveland Area Projects and Western Area Colorado Missouri Balancing Authority Operating Reserve—Supplemental Reserve Service (Approved Under Rate Order No. WAPA–174) Effective The first day of the first full billing period beginning on or after October 1, 2016, and extending through September 30, 2021, or until superseded by another rate schedule, whichever occurs earlier. [Note: This rate schedule was extended by Rate Order No. WAPA–196 through September 30, 2024.] Applicable This rate schedule applies to the Loveland Area Projects (LAPT) as the Transmission Service Provider (TSP) and the Western Area Colorado Missouri Balancing Authority (WACM) as the Control Area operator. Supplemental Reserve Service is needed to serve load in the event of a system contingency; however, it is not available immediately to serve load but rather within a short period of time. Supplemental Reserve Service may be provided by generating units that are on-line but unloaded, by quick-start generation, or by interruptible load. The LAPT TSP must offer this service when the transmission service is used to serve load within WACM and the Federal Transmission Customers must purchase this service from the LAPT TSP or make alternative comparable arrangements with WACM to satisfy their Supplemental Reserve obligations. WACM may be willing to provide Supplemental Reserves to other entities, providing the entities enter into separate agreements with WACM which will specify the terms of the Supplemental Reserve Service. Formula Rate The LAPT TSP and WACM have no Supplemental Reserves available for sale. At a customer’s request, the Rocky Mountain Region will purchase Supplemental Reserves and pass through the cost and any activation energy, plus a fee for administration. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 The customer will be responsible for providing the transmission to deliver the Supplemental Reserves purchased. [FR Doc. 2021–18646 Filed 8–30–21; 8:45 am] SCHEDULE 6 to OATT United States Department of Energy Western Area Power Administration United States Department of Energy Western Area Power Administration 20:08 Aug 30, 2021 Rate Schedule L–AS6 (Supersedes Rate Schedule L–AS6 dated October 1, 2011, through September 30, 2016) SCHEDULE 5 to OATT VerDate Sep<11>2014 transmission to deliver the Spinning Reserves purchased. 48691 ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPP–2019–0274; FRL–8736–01– OCSPP] Pesticide Experimental Use Permit; Receipt of Application; Comment Request Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: This notice announces EPA’s receipt of an application 93167–EUP–2 from Oxitec, Ltd. requesting an amendment and extension to the experimental use permit (EUP) for the OX5034 Aedes aegypti mosquitoes expressing tetracycline Trans-Activator Variant (tTAV–OX5034) protein. The Agency has determined that the permit may be of regional and national significance. Therefore, because of the potential significance, EPA is seeking comments on this application. DATES: Comments must be received on or before September 30, 2021. ADDRESSES: Submit your comments, identified by docket identification (ID) number EPA–HQ–OPP–2019–0274., by one of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. • Mail: OPP Docket, Environmental Protection Agency Docket Center (EPA/ DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. • Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at https:// www.epa.gov/dockets/contacts.html. Due to the public health concerns related to COVID–19, the EPA Docket Center (EPA/DC) and Reading Room is closed to visitors with limited exceptions. The staff continues to provide remote customer service via email, phone, and webform. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: Charles Smith, Biopesticides and SUMMARY: E:\FR\FM\31AUN1.SGM 31AUN1 48692 Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices Pollution Prevention Division (7511P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; main telephone number: (703) 305–7090; email address: BPPDFRNotices@epa.gov. SUPPLEMENTARY INFORMATION: I. General Information A. Does this action apply to me? This action is directed to the public in general. Although this action may be of particular interest to those persons who conduct or sponsor research on pesticides, the Agency has not attempted to describe all the specific entities that may be affected by this action. khammond on DSKJM1Z7X2PROD with NOTICES B. What should I consider as I prepare my comments for EPA? 1. Submitting CBI. Do not submit this information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 2. Tips for preparing your comments. When preparing and submitting your comments, see the commenting tips at https://www.epa.gov/dockets/ comments.html. 3. Environmental justice. EPA seeks to achieve environmental justice, the fair treatment and meaningful involvement of any group, including minority and/or low-income populations, in the development, implementation, and enforcement of environmental laws, regulations, and policies. To help address potential environmental justice issues, the Agency seeks information on any groups or segments of the population who, as a result of their location, cultural practices, or other factors, may have atypical or disproportionately high and adverse human health impacts or environmental effects from exposure to the pesticide(s) discussed in this document, compared to the general population. VerDate Sep<11>2014 20:08 Aug 30, 2021 Jkt 253001 II. What action is the Agency taking? Under section 5 of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), 7 U.S.C. 136c, EPA can allow manufacturers to field test pesticides under development. Manufacturers are required to obtain an EUP before testing new pesticides or new uses of pesticides if they conduct experimental field tests on 10 acres or more of land or one acre or more of water. Pursuant to 40 CFR 172.11(a), the Agency has determined that the following EUP amendment and extension application may be of regional and national significance, and therefore is seeking public comment on the EUP application: Submitter: Oxitec, Ltd., (93167–EUP– 2). Pesticide Chemical: OX5034 Aedes aegypti mosquitoes expressing tetracycline Trans-Activator Variant (tTAV–OX5034) protein. Summary of Request: Oxitec Ltd. is proposing to extend testing of OX5034 Aedes aegypti mosquitoes expressing tTAV–OX5034 protein for 2 years in the state of Florida up to 6,240 total acres at a maximum rate of 0.000082 g active ingredient (tTAV–OX5034), equivalent to 20,000 male OX5034 mosquitoes, per acre, per week. Additionally, Oxitec Ltd is proposing to expand testing of OX5034 Aedes aegypti mosquitoes expressing tTAV–OX5034 protein in the state of California on up to 84,600 total acres at a maximum rate of 0.000123 g active ingredient (tTAV–OX5034), equivalent to 30,000 male OX5034 mosquitoes, per acre, per week. The proposed experiments are to evaluate the efficacy of OX5034 mosquitoes as a tool for suppression of wild Aedes aegypti mosquito populations. Female offspring of the OX5034 mosquitoes in the environment die before they mature into adults and therefore exposure to biting female mosquitoes is not anticipated. EPA made its decision to grant the already issued Oxitec OX5034 Mosquito Experimental Use Permit in April 2020 after extensive evaluation of the best available science, and after seeking and addressing public input. EPA’s risk assessment https:// www.regulations.gov/document/EPAHQ-OPP-2019-0274-0359, and response to comment document https:// www.regulations.gov/document/EPAHQ-OPP-2019-0274-0354, are publicly available and accessible through regulations.gov via these links. Common questions and answers regarding the already issued EUP can be found in the ‘‘The Experimental Use Permit for the PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 Oxitec Genetically Engineered Aedes aegypti Mosquitoes’’ webinar available at https://www.epa.gov/pesticides/ biopesticides. Following the review of the application and any comments and data received in response to this solicitation, EPA will decide whether to issue or deny the EUP request, and if issued, the conditions under which it is to be conducted. Any issuance of an EUP will be announced in the Federal Register. Authority: 7 U.S.C. 136 et seq. Dated: August 25, 2021. Charles Smith, Acting Director, Biopesticides and Pollution Prevention Division, Office of Pesticide Programs. [FR Doc. 2021–18776 Filed 8–30–21; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OAR–2021–0557; FRL–8884–01– OAR] Proposed Information Collection Request; Comment Request; Part 70 State Operating Permit Program (Renewal) Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Environmental Protection Agency is planning to submit an information collection request (ICR), ‘‘Part 70 State Operating Permit Program (Renewal)’’ (EPA ICR No. 1587.15, OMB Control No. 2060–0243) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act (PRA). Before doing so, the EPA is soliciting public comments on specific aspects of the proposed information collection. This is a proposed extension of the ICR, which is currently approved through April 30, 2022. An Agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. DATES: Comments must be submitted on or before November 1, 2021. ADDRESSES: Submit your comments, referencing Docket ID No. EPA–HQ– OAR–2021–0557, online using https:// www.regulations.gov (our preferred method), by email to a-and-r-docket@ epa.gov, or by mail to: EPA Docket Center, Environmental Protection Agency, Mail Code 28221T, 1200 Pennsylvania Avenue NW, Washington, DC 20460. The EPA is temporarily suspending its Docket Center and Reading Room for SUMMARY: E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Pages 48691-48692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18776]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2019-0274; FRL-8736-01-OCSPP]


Pesticide Experimental Use Permit; Receipt of Application; 
Comment Request

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's receipt of an application 93167-
EUP-2 from Oxitec, Ltd. requesting an amendment and extension to the 
experimental use permit (EUP) for the OX5034 Aedes aegypti mosquitoes 
expressing tetracycline Trans-Activator Variant (tTAV-OX5034) protein. 
The Agency has determined that the permit may be of regional and 
national significance. Therefore, because of the potential 
significance, EPA is seeking comments on this application.

DATES: Comments must be received on or before September 30, 2021.

ADDRESSES: Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPP-2019-0274., by one of the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be Confidential Business 
Information (CBI) or other information whose disclosure is restricted 
by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC 
20460-0001.
     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at https://www.epa.gov/dockets/contacts.html.
    Due to the public health concerns related to COVID-19, the EPA 
Docket Center (EPA/DC) and Reading Room is closed to visitors with 
limited exceptions. The staff continues to provide remote customer 
service via email, phone, and webform. For the latest status 
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Charles Smith, Biopesticides and

[[Page 48692]]

Pollution Prevention Division (7511P), Office of Pesticide Programs, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; main telephone number: (703) 305-7090; email address: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general. Although this 
action may be of particular interest to those persons who conduct or 
sponsor research on pesticides, the Agency has not attempted to 
describe all the specific entities that may be affected by this action.

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through 
regulations.gov or email. Clearly mark the part or all of the 
information that you claim to be CBI. For CBI information in a disk or 
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as 
CBI and then identify electronically within the disk or CD-ROM the 
specific information that is claimed as CBI. In addition to one 
complete version of the comment that includes information claimed as 
CBI, a copy of the comment that does not contain the information 
claimed as CBI must be submitted for inclusion in the public docket. 
Information so marked will not be disclosed except in accordance with 
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting 
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.
    3. Environmental justice. EPA seeks to achieve environmental 
justice, the fair treatment and meaningful involvement of any group, 
including minority and/or low-income populations, in the development, 
implementation, and enforcement of environmental laws, regulations, and 
policies. To help address potential environmental justice issues, the 
Agency seeks information on any groups or segments of the population 
who, as a result of their location, cultural practices, or other 
factors, may have atypical or disproportionately high and adverse human 
health impacts or environmental effects from exposure to the 
pesticide(s) discussed in this document, compared to the general 
population.

II. What action is the Agency taking?

    Under section 5 of the Federal Insecticide, Fungicide and 
Rodenticide Act (FIFRA), 7 U.S.C. 136c, EPA can allow manufacturers to 
field test pesticides under development. Manufacturers are required to 
obtain an EUP before testing new pesticides or new uses of pesticides 
if they conduct experimental field tests on 10 acres or more of land or 
one acre or more of water.
    Pursuant to 40 CFR 172.11(a), the Agency has determined that the 
following EUP amendment and extension application may be of regional 
and national significance, and therefore is seeking public comment on 
the EUP application:
    Submitter: Oxitec, Ltd., (93167-EUP-2).
    Pesticide Chemical: OX5034 Aedes aegypti mosquitoes expressing 
tetracycline Trans-Activator Variant (tTAV-OX5034) protein.
    Summary of Request: Oxitec Ltd. is proposing to extend testing of 
OX5034 Aedes aegypti mosquitoes expressing tTAV-OX5034 protein for 2 
years in the state of Florida up to 6,240 total acres at a maximum rate 
of 0.000082 g active ingredient (tTAV-OX5034), equivalent to 20,000 
male OX5034 mosquitoes, per acre, per week. Additionally, Oxitec Ltd is 
proposing to expand testing of OX5034 Aedes aegypti mosquitoes 
expressing tTAV-OX5034 protein in the state of California on up to 
84,600 total acres at a maximum rate of 0.000123 g active ingredient 
(tTAV-OX5034), equivalent to 30,000 male OX5034 mosquitoes, per acre, 
per week. The proposed experiments are to evaluate the efficacy of 
OX5034 mosquitoes as a tool for suppression of wild Aedes aegypti 
mosquito populations. Female offspring of the OX5034 mosquitoes in the 
environment die before they mature into adults and therefore exposure 
to biting female mosquitoes is not anticipated.
    EPA made its decision to grant the already issued Oxitec OX5034 
Mosquito Experimental Use Permit in April 2020 after extensive 
evaluation of the best available science, and after seeking and 
addressing public input. EPA's risk assessment https://www.regulations.gov/document/EPA-HQ-OPP-2019-0274-0359, and response to 
comment document https://www.regulations.gov/document/EPA-HQ-OPP-2019-0274-0354, are publicly available and accessible through 
regulations.gov via these links. Common questions and answers regarding 
the already issued EUP can be found in the ``The Experimental Use 
Permit for the Oxitec Genetically Engineered Aedes aegypti Mosquitoes'' 
webinar available at https://www.epa.gov/pesticides/biopesticides.
    Following the review of the application and any comments and data 
received in response to this solicitation, EPA will decide whether to 
issue or deny the EUP request, and if issued, the conditions under 
which it is to be conducted. Any issuance of an EUP will be announced 
in the Federal Register.
    Authority: 7 U.S.C. 136 et seq.

    Dated: August 25, 2021.
Charles Smith,
Acting Director, Biopesticides and Pollution Prevention Division, 
Office of Pesticide Programs.
[FR Doc. 2021-18776 Filed 8-30-21; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.